A recent study assess whether our most essential communication tools (smartphones) are silent vectors for infection, revealing that 64.3% of smartphones used by nursing staff in the Intensive Care Unit…
A new study published in the Journal of American Medical Association showed no differences in mortality or recurrence between the AMBITION treatment and a daily amphotericin-based regimen in HIV-associated cryptococcal…
Korea: Researchers have found in a new study that within one month of treatment, patients showed an average myopic shift of 0.22 D, and over 13% experienced a shift of…
The prenatal period is a critical window for brain development, yet few studies have examined the impact of air pollution exposure during pregnancy on child cognition. A new study led…
Tumors in the human body contain immune cells called macrophages that are naturally capable of attacking cancer. However, tumors suppress these cells, preventing them from carrying out their cancer-fighting role.…
A major new study has uncovered gene clues that could pave the way to personalised psoriasis treatments. Psoriasis is a common inflammatory skin disease linked to several long-term health conditions,…
A recent randomized, double-blind, placebo-controlled clinical trial found that duloxetine significantly reduced the frequency and sensitivity of refractory chronic cough (RCC) compared with placebo. Patients treated with duloxetine had a…
In patients with peripheral vascular disease (PVD) undergoing peripheral vascular intervention (PVI), both intravenous and oral hydration protocols were effective and safe in preventing contrast-induced nephropathy (CIN). Oral hydration was…
Chlamydia pneumoniae-a common bacterium that causes pneumonia and sinus infections-can linger in the eye and brain for years and may aggravate Alzheimer’s disease, according to a study from Cedars-Sinai. Published…
There is no consensus of whether to use a short or long intramedullary nail (IMN) in the treatment of trochanteric and subtrochanteric fractures. In the retrospective cohort study, Peter Sverre…